✦ LIBER ✦

PCN28 Capecitabine for the Treatment of Breast Cancer in Private Health System in Brazil: Cost analysis Based on Real World Data

✍ Scribed by Clark, O.; Clark, L.G.O.; Botrel, T.E.A.; Rosa, B.; Medina, P.; Paladini, L.; Fiol, E.; Rodrigues, N.; Faleiros, E.; Castro, A.P.; Fortes, A.F.

Book ID: 122121717
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 57 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.08.1129

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN35 Capecitabine for the Treatment of

PCN35 Capecitabine for the Treatment of Colorectal Cancer in Private Health System in Brazil: A Budgetary Impact Analysis Based on Real World Data

✍ Clark, O.; Clark, L.G.O.; Botrel, T.E.A.; Paladini, L.; Medina, P.; Rosa, B.; Fi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PCN146 REAL WORLD DATA ON MULTIPLE MYELO

PCN146 REAL WORLD DATA ON MULTIPLE MYELOMA (MM) TREATMENT IN BRAZIL: GUIDANCE FOR THE PRIVATE HEALTH CARE SYSTEM (PHS)

✍ AFF Alves; APC Castro; LGO Clark; FS Santos; O Clark; T Engel; B Pegoretti 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PCN29 Budgetary Impact of Adoption of Er

PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil: A Real World Data Analysis

✍ Clark, O.; Clark, L.G.O.; Botrel, T.E.A.; Medina, P.; Paladini, L.; Rosa, B.; Ro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN24 COST-EFFECTIVENESS ANALYSIS OF LAP

PCN24 COST-EFFECTIVENESS ANALYSIS OF LAPATINIB ASSOCIATED TO CAPECITABINE VERSUS CAPECITABINE ALONE AND OF TRASTUZUMAB ASSOCIATED TO CAPECITABINE VERSUS CAPECITABINE ALONE IN THE TREATMENT OF METASTATIC BREAST CANCER UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE

✍ Teich, V; Passos, RBF; Teich, N; Canella, M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCN33 Indirect Analysis of the Efficacy

PCN33 Indirect Analysis of the Efficacy and Safety of Pemetrexed/Cisplatin Compared With Bevacizumab/Gemcitabine/Cisplatin as First-Line Treatment for Advanced, Non-Squamous Non-Small Cell Lung Cancer and Associated Treatment Costs in the Private Mexican Health Care System

✍ Ramirez Gamez, J.; Cruz Cadena, A.; Davey, P.; Rajan, N.; Barraclough, H.; Orlan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCN67 LOWER ADMINISTRATION COSTS OF BEVA

PCN67 LOWER ADMINISTRATION COSTS OF BEVACIZUMAB IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY VERSUS CETUXIMAB-VINORELBINE-CISPLATIN THERAPY FOR THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC) FOCUSING ON THREE EUROPEAN HEALTH CARE SYSTEMS

✍ H Rosery; C Castro de; H Bischoff; D Heigener; A Vergnenegre; C Chouaid; S Walze 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB